Coherus Biosciences, Redwood City, CA

Coherus Biosciences

www.coherus.com

Coherus BioSciences is the leading biologics platform company solely focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medicines in regulated markets worldwide. Founded in 2010, Coherus is a late-stage biologics platform company focused on the global biosimilar market. Headquartered in the San Francisco Bay Area and composed of a team of industry veterans with decades of experience in pioneering biologics companies, our goal is to become a global leader in the biosimilar market by leveraging our team`s collective expertise in key areas such as process science, analytical characterization, protein production and clinical-regulatory development. Our commercialization ...

More>>

Number of Employees: 25-100
Annual Revenue: $50-100 Million

www.coherus.com
333 Twin Dolphin Drive Suite 600
Redwood City, CA USA 94065
Phone: 800.794.5434

Name	Title	Contact Details
Kristina Bartlett	Senior Director, HR Commercial	Profile
Rosh Dias	CMO	Profile
Diliana Stoilova	Vice President and Head of Product Development	Profile
Abid Rahman	Senior Vice President- Commercial & New Product Planning	Profile
James Thompson	Executive Director, Drug & Finished Product Manufacturing	Profile

Similar Companies

Aqualung Therapeutics

Aqualung Therapeutics (ALT) is developing multi-pronged strategies to address the development of severe lung inflammation which is essential to the severity and outcomes of acute and chronic lung disorders such as acute lung injury, ventilator-induced lung injury (VILI), idiopathic pulmonary fibrosis, and pulmonary hypertension.

Taysha Gene Therapies

Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we hope to rapidly translate our treatments from bench to bedside. We have combined our team`s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to quickly and efficiently build an extensive, AAV gene therapy pipeline focused on both rare and large-market indications. Together, we leverage our fully integrated platform—an engine for new cures—to dramatically improve patients` lives.

HR Execs on the Move